Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF OPERATIONS

v3.21.1
STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Operating expenses:    
Research and development $ 2,866 $ 22,194
Research and development - licenses acquired 0 1,000
General and administrative 2,347 3,071
Loss from operations (5,213) (26,265)
Interest income (62) (357)
Net Loss $ (5,151) $ (25,908)
Net loss per common share outstanding, basic and diluted $ (0.31) $ (1.65)
Weighted average number of common shares outstanding, basic and diluted 16,506,447 15,721,619